Join
Live feed
·
INSIDERFilingvia Quantisnow
Indivior Pharmaceuticals Inc. logo

Director Stejbach Mark was granted 3,722 shares, increasing direct ownership by 22% to 20,569 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
INDV· Indivior Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INDV (Indivior Pharmaceuticals Inc.) and more on Quantisnow.